Fischer will join Fresenius Medical Care as CFO starting on Oct. 1, the company announced Monday. The Germany-based firm, which makes dialysis products and operates a network of clinics, has shuffled its leadership as parent company Fresenius plans to spin out the unit by the end of the year.
In December, Fresenius Medical Care promoted CFO Helen Giza to CEO. Giza will continue to serve as acting CFO for the company until Fischer starts this fall. When the company becomes a German stock corporation, Fischer will become a member of Fresenius Medical Care’s board.
“Martin Fischer has proven that he can successfully drive fundamental change in organizations. In our organizational transformation and turnaround management, we will benefit from his finance and healthcare expertise,” Giza said in a statement. “Martin will be an important contributor to the execution of our strategy in unlocking value as the leading kidney care company.”
Fischer joins the company after working as head of finance for the Siemens Healthineers Diagnostic Division. Before that, he held other operational and finance positions at Siemens.
He will be based in Bad Homburg, Germany, and will be responsible for Fresenius Medical Care’s global finance.
by Elise Reuter
Source: medtechdive.com
CordenPharma announced its largest strategic investment to date, committing to spend ~€900m over the next three years to enhance its peptide technology platform. The planned investment consists of two major expansion initiatives occurring in parallel in the US and Europe, including both existing facilities and new constructions.
DSM-Firmenich has announced the sale of its MEG-3 fish oil business to KD Pharma Group, a contract development and manufacturing organisation that is active in pharmaceutical and nutritional lipids. As part of the transaction, DSM-Firmenich will obtain a minority stake of 29% in KD Pharma’s parent company O³ Holding GmbH.
Veranova, a development and manufacturing of specialist and complex APIs for the pharmaceutica l and biotech sectors, recently announced the appointment of Cécile Maupas as Senior Vice President, Chief Commercial Officer. Cécile will join the executive team and assume responsibility for business development, marketing, project management, commercial operations, and product management.
